Shanshan Ma

Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Targeted microwave sensitizers reprogram cancer-associated fibroblasts via nitric oxide delivery to potentiate hepatocellular carcinoma therapy.

Targeted microwave sensitizers reprogram cancer-associated fibroblasts via nitric oxide delivery to potentiate hepatocellular carcinoma therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 19, 2026

Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.

Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.

Journal: Therapeutic advances in medical oncology
Published: May 04, 2025

Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.

Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.

Journal: Insights into imaging
Published: January 15, 2025

Dual-Synergistic Nanomodulator Alleviates Exosomal PD-L1 Expression Enabling Exhausted Cytotoxic T Lymphocytes Rejuvenation for Potentiated iRFA-Treated Hepatocellular Carcinoma Immunotherapy.

Dual-Synergistic Nanomodulator Alleviates Exosomal PD-L1 Expression Enabling Exhausted Cytotoxic T Lymphocytes Rejuvenation for Potentiated iRFA-Treated Hepatocellular Carcinoma Immunotherapy.

Journal: ACS nano
Published: November 11, 2024

Dual-modality immune nano-activator harnessing Mn2⁺ and quercetin to potentiate the cGAS-STING pathway for advanced cancer metalloimmunotherapy.

Dual-modality immune nano-activator harnessing Mn2⁺ and quercetin to potentiate the cGAS-STING pathway for advanced cancer metalloimmunotherapy.

Journal: Journal of nanobiotechnology
Published: October 29, 2024

The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.

The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.

Journal: Frontiers in oncology
Published: October 20, 2024

Acoustically activated nanoplatforms achieve tumor regression by exacerbating tumor hypoxia.

Acoustically activated nanoplatforms achieve tumor regression by exacerbating tumor hypoxia.

Journal: Journal of cancer research and therapeutics
Published: September 21, 2024

Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer.

Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer.

Journal: Materials today. Bio
Published: August 30, 2024

Dose-Volume Parameters of Spared Magnetic Resonance Imaging-Defined Active Bone Marrow Predict Hematologic Toxicity in Pelvic Malignancies Patients Undergoing Radiotherapy: A Cohort Study.

Dose-Volume Parameters of Spared Magnetic Resonance Imaging-Defined Active Bone Marrow Predict Hematologic Toxicity in Pelvic Malignancies Patients Undergoing Radiotherapy: A Cohort Study.

Journal: Technology in cancer research & treatment
Published: May 16, 2024

The Role of Radiotherapy for Metastatic Cervical Cancer: A Real-World Study.

The Role of Radiotherapy for Metastatic Cervical Cancer: A Real-World Study.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 10, 2024

Risk Factor Analysis and Prediction of Para-Aortic Lymph Node Metastases in Locally Advanced Cervical Cancer.

Risk Factor Analysis and Prediction of Para-Aortic Lymph Node Metastases in Locally Advanced Cervical Cancer.

Journal: Cancer medicine
Published: March 06, 2024

Prognostic analysis of stage IIIC1p cervical cancer patients.

Prognostic analysis of stage IIIC1p cervical cancer patients.

Journal: Frontiers in oncology
Published: December 28, 2023
Showing 1-12 of 21

Last Updated: 09/26/2026